| Authors: |
Płonka M; Roche Polska Sp. z o.o., Warsaw, Poland., Klimas R; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Stanev D; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Angelini L; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Napiórkowski N; Roche Polska Sp. z o.o., Warsaw, Poland., González Chan G; School of Health Professions, University of Plymouth, Plymouth, UK., Bunn L; School of Health Professions, University of Plymouth, Plymouth, UK., Glazier PS; School of Health Professions, University of Plymouth, Plymouth, UK., Hosking R; University of Plymouth Enterprise Ltd, Plymouth, UK., Freeman J; School of Health Professions, University of Plymouth, Plymouth, UK., Hobart J; Peninsula Medical School, Faculty of Health, University of Plymouth, Plymouth, UK., Zanon M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Marsden J; School of Health Professions, University of Plymouth, Plymouth, UK., Craveiro L; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Rinderknecht MD; F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: mike.rinderknecht@roche.com. |